| Whole Chromosome Instability induces senescence and promotes SASP GA Andriani, VP Almeida, F Faggioli, M Mauro, WL Tsai, L Santambrogio, ... Scientific reports 6 (1), 35218, 2016 | 138 | 2016 |
| In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools ACB Antonelli, VP Almeida, FOF de Castro, JM Silva, IAH Pfrimer, ... Scientific reports 12 (1), 53, 2022 | 22 | 2022 |
| Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy J McAuliffe, HF Chan, L Noblecourt, RA Ramirez-Valdez, ... Journal for immunotherapy of cancer 9 (9), 2021 | 14 | 2021 |
| Protease-Based Subunit Vaccine in Mice Boosts BCG Protection against Mycobacterium tuberculosis AP Junqueira-Kipnis, C de Castro Souza, AC de Oliveira Carvalho, ... Vaccines 10 (2), 306, 2022 | 3 | 2022 |
| 835 Heterologous prime boost viral vector vaccination provides protection against intracranial syngeneic murine glioblastoma EE Steffke, T Hana, L Latifi, VP Almeida, J McAuliffe, A Wicki, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Immunoinformatics Vaccine Design for Zika Virus AC Antonelli, VP Almeida, SG da Fonseca Computational Vaccine Design, 411-429, 2023 | | 2023 |
| Heterologous prime-boost viral vector cancer vaccines have protective effects against a syngeneic mouse model of glioblastoma EE Steffke, L Noblecourt, VP Almeida, A Wicki, J McAuliffe, G Kohanbash, ... The Journal of Immunology 210 (1_Supplement), 145.12-145.12, 2023 | | 2023 |
| Heterologous prime-boost viral vector vaccines for the treatment of a P1A-expressing BGL-1 glioblastoma model EE Steffke, J McAuliffe, VP Almeida, A Wicki, L Noblecourt, G Kohanbash, ... Cancer Research 83 (7_Supplement), 682-682, 2023 | | 2023 |
| Chemotherapy synergizes with cancer vaccines and expands stem-like TCF1+ CD8+ T cells L Noblecourt, A Wicki, V Pereira-Almeida, J McAuliffe, E Steffke, S Panetti, ... bioRxiv, 2023.12. 18.572068, 2023 | | 2023 |
Massimo GadinaTranslational Immunology Section Office of Science and Technology, NIAMS, NIHVerified email at mail.nih.gov
